Clinical Trial Update: Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating regorafenib in combination with irinotecan drug-eluting beads for colorectal cancer liver metastases is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer Liver Metastases

Drugs mentioned

• Irinotecan drug-eluting beads (irinotecan)
• Regorafenib (regorafenib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer Liver Metastases, Regorafenib | Phase 3 | Status: RECRUITING